File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Human papillomavirus type distribution in women from Asia: A meta-analysis

TitleHuman papillomavirus type distribution in women from Asia: A meta-analysis
Authors
KeywordsAsia
Cervix
Human papillomavirus
Meta-analysis
Type distribution
Issue Date2008
PublisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.ijgc.net/
Citation
International Journal Of Gynecological Cancer, 2008, v. 18 n. 1, p. 71-79 How to Cite?
AbstractThe aim of this study was to determine human papillomavirus (HPV) type distribution in women with and without cervical neoplasia from Asia and to estimate the potential future impact of an HPV 16/18 prophylactic vaccine in this region. A meta-analysis was conducted including 79 studies using polymerase chain reaction to detect HPV types. A total of 5954, 1653, 958, and 16,803 women with invasive cervical cancer (ICC), high-grade squamous intraepithelial lesions (HSIL), low-grade squamous intraepithelial lesions (LSIL), and normal cytology or histology were included, respectively. Type-specific prevalence of HPV types 6, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, 70, 73, and 82 were estimated and stratified by cervical lesion grade. Overall HPV prevalence was 85.9%, 81.0%, 72.9%, and 14.4%, respectively, in women with ICC, HSIL, LSIL, and normal cytology/histology. In ICC, HPV 16 was the predominant type (52.4%), followed by HPV 18, 58, 33, 52, 45, 31, and 35. The estimated HPV 16/18-positive fraction was 66.9%, 40.4%, 26.7%, and 3.3% in women with ICC, HSIL, LSIL, and normal cytology or histology, respectively. In ICC, the estimated HPV 16/18-positive fraction was about 70% in all Asian geographic regions, with the exception of Japan (51.3%). HPV 16/18 vaccines are estimated to provide about 67% protection against ICC in Asia. HPV 58 and 52 were among the five most common types in ICC in eastern and southeastern Asia but not in south central Asia. After HPV 16 and 18, the next most six common HPV types were 58, 33, 52, 45, 31, and 35 that accounted for additional 20% of cervical cancer cases in Asia. For optimal population coverage, these HPV carcinogenic types should be considered for second-generation HPV prophylactic vaccines. © 2007, Copyright the Authors.
Persistent Identifierhttp://hdl.handle.net/10722/148537
ISSN
2015 Impact Factor: 2.116
2015 SCImago Journal Rankings: 0.830
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorBao, YPen_HK
dc.contributor.authorLi, Nen_HK
dc.contributor.authorSmith, JSen_HK
dc.contributor.authorQiao, YLen_HK
dc.contributor.authorTan, Jen_HK
dc.contributor.authorLiu, Jen_HK
dc.contributor.authorNgan, HYSen_HK
dc.contributor.authorCheung, ANYen_HK
dc.contributor.authorBhatla, Nen_HK
dc.contributor.authorPutra, ADen_HK
dc.contributor.authorPark, JSen_HK
dc.contributor.authorKim, YTen_HK
dc.contributor.authorRuey, Sen_HK
dc.contributor.authorLimson, Gen_HK
dc.contributor.authorChow, SNen_HK
dc.contributor.authorWang, KLen_HK
dc.contributor.authorTermrungruanglert, Wen_HK
dc.contributor.authorPancharoen, Cen_HK
dc.date.accessioned2012-05-29T06:13:35Z-
dc.date.available2012-05-29T06:13:35Z-
dc.date.issued2008en_HK
dc.identifier.citationInternational Journal Of Gynecological Cancer, 2008, v. 18 n. 1, p. 71-79en_HK
dc.identifier.issn1048-891Xen_HK
dc.identifier.urihttp://hdl.handle.net/10722/148537-
dc.description.abstractThe aim of this study was to determine human papillomavirus (HPV) type distribution in women with and without cervical neoplasia from Asia and to estimate the potential future impact of an HPV 16/18 prophylactic vaccine in this region. A meta-analysis was conducted including 79 studies using polymerase chain reaction to detect HPV types. A total of 5954, 1653, 958, and 16,803 women with invasive cervical cancer (ICC), high-grade squamous intraepithelial lesions (HSIL), low-grade squamous intraepithelial lesions (LSIL), and normal cytology or histology were included, respectively. Type-specific prevalence of HPV types 6, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, 70, 73, and 82 were estimated and stratified by cervical lesion grade. Overall HPV prevalence was 85.9%, 81.0%, 72.9%, and 14.4%, respectively, in women with ICC, HSIL, LSIL, and normal cytology/histology. In ICC, HPV 16 was the predominant type (52.4%), followed by HPV 18, 58, 33, 52, 45, 31, and 35. The estimated HPV 16/18-positive fraction was 66.9%, 40.4%, 26.7%, and 3.3% in women with ICC, HSIL, LSIL, and normal cytology or histology, respectively. In ICC, the estimated HPV 16/18-positive fraction was about 70% in all Asian geographic regions, with the exception of Japan (51.3%). HPV 16/18 vaccines are estimated to provide about 67% protection against ICC in Asia. HPV 58 and 52 were among the five most common types in ICC in eastern and southeastern Asia but not in south central Asia. After HPV 16 and 18, the next most six common HPV types were 58, 33, 52, 45, 31, and 35 that accounted for additional 20% of cervical cancer cases in Asia. For optimal population coverage, these HPV carcinogenic types should be considered for second-generation HPV prophylactic vaccines. © 2007, Copyright the Authors.en_HK
dc.languageengen_US
dc.publisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.ijgc.net/en_HK
dc.relation.ispartofInternational Journal of Gynecological Canceren_HK
dc.subjectAsiaen_HK
dc.subjectCervixen_HK
dc.subjectHuman papillomavirusen_HK
dc.subjectMeta-analysisen_HK
dc.subjectType distributionen_HK
dc.subject.meshAsia - Epidemiologyen_US
dc.subject.meshCarcinoma, Squamous Cell - Epidemiology - Prevention & Control - Virologyen_US
dc.subject.meshCervical Intraepithelial Neoplasia - Prevention & Control - Virologyen_US
dc.subject.meshClinical Trials As Topicen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshPapillomaviridae - Classification - Isolation & Purificationen_US
dc.subject.meshPapillomavirus Infections - Epidemiology - Prevention & Control - Virologyen_US
dc.subject.meshPapillomavirus Vaccinesen_US
dc.subject.meshPrevalenceen_US
dc.subject.meshRisk Factorsen_US
dc.subject.meshUterine Cervical Neoplasms - Epidemiology - Prevention & Control - Virologyen_US
dc.titleHuman papillomavirus type distribution in women from Asia: A meta-analysisen_HK
dc.typeArticleen_HK
dc.identifier.emailNgan, HYS:hysngan@hkucc.hku.hken_HK
dc.identifier.emailCheung, ANY:anycheun@hkucc.hku.hken_HK
dc.identifier.authorityNgan, HYS=rp00346en_HK
dc.identifier.authorityCheung, ANY=rp00542en_HK
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1111/j.1525-1438.2007.00959.xen_HK
dc.identifier.pmid17466054en_HK
dc.identifier.scopuseid_2-s2.0-38049052407en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-38049052407&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume18en_HK
dc.identifier.issue1en_HK
dc.identifier.spage71en_HK
dc.identifier.epage79en_HK
dc.identifier.isiWOS:000252208100011-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridBao, YP=35760147100en_HK
dc.identifier.scopusauthoridLi, N=27170796800en_HK
dc.identifier.scopusauthoridSmith, JS=7410179914en_HK
dc.identifier.scopusauthoridQiao, YL=7202252853en_HK
dc.identifier.scopusauthoridTan, J=8081461000en_HK
dc.identifier.scopusauthoridLiu, J=16042459100en_HK
dc.identifier.scopusauthoridNgan, HYS=34571944100en_HK
dc.identifier.scopusauthoridCheung, ANY=54927484100en_HK
dc.identifier.scopusauthoridBhatla, N=7003352680en_HK
dc.identifier.scopusauthoridPutra, AD=23390421400en_HK
dc.identifier.scopusauthoridPark, JS=15768139500en_HK
dc.identifier.scopusauthoridKim, YT=34868238700en_HK
dc.identifier.scopusauthoridRuey, S=55302789900en_HK
dc.identifier.scopusauthoridLimson, G=16645917700en_HK
dc.identifier.scopusauthoridChow, SN=7201828330en_HK
dc.identifier.scopusauthoridWang, KL=10438759700en_HK
dc.identifier.scopusauthoridTermrungruanglert, W=6602997018en_HK
dc.identifier.scopusauthoridPancharoen, C=7006397913en_HK
dc.identifier.citeulike2215189-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats